Validity of Thinnest Point Percentage Tissue Altered As a Screening Formula for Post-LASIK Ectasia in Indian Eyes | ASCRS
Presentation
Validity of Thinnest Point Percentage Tissue Altered As a Screening Formula for Post-LASIK Ectasia in Indian Eyes
May 2020
Meeting: 2020 Virtual Annual Meeting
Session: SPS-114 Keratorefractive Surgical Planning
Authors: Ruchita Manaktala, DOMS, DNB, Karan Bhatia DOMS, DNB, K.V. Satyamurthy MS
This content is only available for ASCRS Members

This content from the 2020 ASCRS Virtual Annual Meeting is only available to ASCRS members. To log in, click the teal "Login" button in the upper right-hand corner of this page.

Purpose
To calculate the thinnest point percentage tissue altered (TP-PTA) in post-laser assisted in situ keratomileusis (LASIK) eyes and to validate its role as an independent factor to evaluate ectasia in Indian population.

Methods
333 consecutive eyes who underwent LASIK using a microkeratome with normal pre-operative corneal topography by combined Placido and Scheimpflug Imaging based topography system (SIRIUS) between 2011 and 2014 at a tertiary level teaching hospital in south India were retrospectively analysed. Pre-operative data collected included patient’s refraction, flap thickness (FT), ablation depth (AD), residual stromal bed (RSB) and thinnest corneal thickness (TCT). TP-PTA was calculated as (FT+AD)/TCT. TP-PTA was grouped into <0.4 (low risk), 0.4-0.45 (moderate risk) and >0.45 (high risk). All patients were called for follow up and underwent a topography to look for ectasia.

Results
60.1%, 29.1% and 10.8% patients had TP-PTA of <0.4, 0.4-0.45 and >0.45 respectively. However, after a minimum follow up of 2 years, none of the patients had any sign of ectasia.

Conclusion
Careful selection of patients is mandatory before proceeding for LASIK. Role of TP-PTA >0.4 as an independent risk factor for post-LASIK ectasia is questionable in Indian eyes, with TCT , RSB, degree of myopia, AD and normal corneal tomography being more important. A modified formula needs to be investigated.
View More Presentations from this Session

This presentation is from the session "SPS-114 Keratorefractive Surgical Planning" from the 2020 ASCRS Virtual Annual Meeting held on May 16-17, 2020.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.